Edition:
United Kingdom

Aeglea Bio Therapeutics Inc (AGLE.OQ)

AGLE.OQ on NASDAQ Stock Exchange Global Market

7.87USD
4:48pm GMT
Change (% chg)

$0.03 (+0.38%)
Prev Close
$7.84
Open
$7.79
Day's High
$8.06
Day's Low
$7.74
Volume
12,176
Avg. Vol
51,145
52-wk High
$12.00
52-wk Low
$3.75

Chart for

About

Aeglea BioTherapeutics, Inc. is a biotechnology company, which is engaged in the development of enzyme-based therapeutics in the field of amino acid metabolism to treat inborn errors of metabolism (IEM) and cancer. The Company's product pipeline includes AEB1102, AEB3103, AEB2109 and AEB4104. Its lead product candidate, AEB1102,... (more)

Overall

Beta: --
Market Cap(Mil.): $87.77
Shares Outstanding(Mil.): 16.45
Dividend: --
Yield (%): --

Financials

  AGLE.OQ Industry Sector
P/E (TTM): -- 85.49 33.64
EPS (TTM): -1.82 -- --
ROI: -36.00 -0.29 14.22
ROE: -36.04 0.40 15.99

Earnings vs. Estimates